Who Exports Aminophylline from India — 151 Suppliers Behind a $5.9M Market
India's aminophylline export market is supplied by 151 active exporters who collectively shipped $5.9M across 582 shipments. LINCOLN PHARMACEUTICALS LTD leads with a 53.6% market share, followed by ARCO PHARMA PRIVATE LIMITED and SRS PHARMACEUTICALS PRIVATE LIMITED. The top 5 suppliers together control 66.8% of total export value, reflecting a concentrated market structure.
Top Aminophylline Exporters from India — Ranked by Export Value
LINCOLN PHARMACEUTICALS LTD is the leading aminophylline exporter from India, holding a 53.6% share of the $5.9M market across 582 shipments from 151 exporters. The top 5 suppliers — LINCOLN PHARMACEUTICALS LTD, ARCO PHARMA PRIVATE LIMITED, SRS PHARMACEUTICALS PRIVATE LIMITED, MANCARE PHARMACEUTICALS PRIVATE LIMITED, LINCOLN PHARMACEUTICALS LIMITED — collectively control 66.8% of total export value, indicating a moderately concentrated market. Individual shares are: LINCOLN PHARMACEUTICALS LTD (53.6%), ARCO PHARMA PRIVATE LIMITED (4.2%), SRS PHARMACEUTICALS PRIVATE LIMITED (3.1%), MANCARE PHARMACEUTICALS PRIVATE LIMITED (3.0%), LINCOLN PHARMACEUTICALS LIMITED (2.9%).
Top Aminophylline Exporters from India
Ranked by export value · 151 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | LINCOLN PHARMACEUTICALS LTD AMINOPHYLLINE TABLETS B.P 100 MG (35237XAMINOPHYLLINE INJECTION BP 25 MG (6951X1AMINOPHYLLINE TABLETS BP 100 MG | $3.1M | 4 | 53.6% |
| 2 | ARCO PHARMA PRIVATE LIMITED AMINOPHYLLINE TABLETS B.P 100 MG (35237XAMINOPHYLLINE INJECTION BP 25 MG (6951X1AMINOPHYLLINE INJECTION B.P. 25 MG 8826 | $248.0K | 4 | 4.2% |
| 3 | SRS PHARMACEUTICALS PRIVATE LIMITED | $184.0K | 1 | 3.1% |
| 4 | MANCARE PHARMACEUTICALS PRIVATE LIMITED | $175.7K | 1 | 3.0% |
| 5 | LINCOLN PHARMACEUTICALS LIMITED AMINOPHYLLINE TABLETS B.P 100 MG (35237XAMINOPHYLLINE INJECTION BP 25 MG (6951X1AMINOPHYLLINE TABLETS BP 100 MG | $167.6K | 3 | 2.9% |
| 6 | OCEAN PHARMACEUTICAL AMINOPHYLLINE INJ. BP 250MG/10ML X 5 AMPAMINOPHYLLINE INJ. BP 250MG/10ML X 5 AMPOULES | $107.5K | 4 | 1.8% |
| 7 | SCOTT EDIL PHARMACIA LIMITED AGO-AMIN TABLETS.CONT:AS PER INVOICE | $106.3K | 3 | 1.8% |
| 8 | BHARAT PARENTERALS LIMITED AMINOPHYLLINE TABLETS BP 100 MGAMINOPHYLLINE TABLETS BP 100 MG 1000TAMINOPHYLLINE TABLETS BP 100 MG AMINOGEN41422X10X10 TAB | $92.6K | 2 | 1.6% |
| 9 | ANGEL BIOGENICS PRIVATE LIMITED | $85.6K | 3 | 1.5% |
| 10 | NEON LABORATORIES LIMITED | $82.0K | 2 | 1.4% |
| 11 | BDH INDUSTRIES LIMITED AMINOPHYLLINE TABLETS BP 100 MGAMINOPHYLLINE TABLETS BP 100 MG 1000TAMINOPHYLLINE TABLETS BP 100 MG AMINOGEN41422X10X10 TAB | $54.7K | 2 | 0.9% |
| 12 | AGOG PHARMA LIMITED AMINOPHYLLINE TABLETS B.P 100 MG (35237XAMINOPHYLLINE INJECTION BP 25 MG (6951X1AMINOPHYLLINE INJECTION B.P. 25 MG 8826 | $39.9K | 2 | 0.7% |
| 13 | ARBRO PHARMACEUTICALS PRIVATE LIMITED | $38.4K | 2 | 0.7% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Aminophylline exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| LINCOLN PHARMACEUTICALS LTD | Not Listed | Yes | Yes | Not verified | EU GMP certification received for Khatraj facility in May 2020. |
| SCOTT EDIL PHARMACIA LIMITED | Not Listed | Yes | No | Not verified | WHO GMP certification valid until January 24, 2028. |
TransData Nexus reviewed the regulatory standing of 2 leading Aminophylline exporters from India. 0 hold US FDA facility approvals, 2 maintain WHO-GMP certification, and 1 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Aminophylline sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for pharmaceutical manufacturing. The city hosts Genome Valley, India's first biotech cluster, and is home to over 800 pharmaceutical companies, including industry leaders like Dr. Reddy's Laboratories, Aurobindo Pharma, and Divi's Laboratories. This concentration of firms, coupled with advanced R&D infrastructure and a skilled talent pool from institutions such as the National Institute of Pharmaceutical Education and Research (NIPER) and the Indian Institute of Chemical Technology (IICT), positions Hyderabad as a key player in the production of active pharmaceutical ingredients (APIs) and bulk drugs.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its robust pharmaceutical ecosystem, contributing nearly 28% of India's pharmaceutical production. This region is home to major companies like Zydus Cadila, Intas Pharmaceuticals, Torrent Pharmaceuticals, and Cadila Pharmaceuticals. The strong support infrastructure, including well-developed ports, roads, power, and water facilities, enhances the region's capacity for large-scale pharmaceutical manufacturing, particularly in formulations.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a strategic export gateway for India's pharmaceutical industry. Mumbai, being the financial capital, provides access to major ports and international markets, facilitating the export of pharmaceutical products. The region hosts numerous pharmaceutical companies, including S Kant Healthcare Ltd, which offers a range of formulations, including aminophylline tablets and injections.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi, located in the Solan district of Himachal Pradesh, has emerged as India's largest pharmaceutical manufacturing hub by volume. The region houses over 1,000 pharmaceutical manufacturing units, including major players like Cipla, Dr. Reddy's Laboratories, and Cadila Healthcare. Baddi's strategic location, favorable government policies, and tax incentives have attracted significant investment, making it a key area for pharmaceutical production.
5Sourcing Recommendations
- Diversify Supplier Base: While Lincoln Pharmaceuticals Ltd dominates aminophylline exports, consider engaging with other manufacturers such as Aarti Pharmalabs Limited, which offers aminophylline and has a strong presence in the API sector.
- Leverage Regional Strengths: Utilize the specialized capabilities of different pharmaceutical clusters. For instance, source bulk drugs from Hyderabad and formulations from the Ahmedabad-Vadodara region to optimize quality and cost.
- Ensure Regulatory Compliance: Engage with suppliers who adhere to international regulatory standards, such as those with USFDA, EUGMP, or WHO certifications, to ensure product quality and facilitate smoother export processes.
- Monitor Export Trends: Keep track of export data and market demands in key destinations like Tanzania, Serbia, and Nigeria to align sourcing strategies with market needs and identify emerging opportunities.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Aminophylline exporters from India
Lincoln Pharmaceuticals Limited — NCLT approves Lincoln Parenteral merger with Lincoln Pharmaceuticals
The National Company Law Tribunal (NCLT) approved the amalgamation of Lincoln Parenteral Limited with Lincoln Pharmaceuticals Limited. - IMPACT: This merger is expected to enhance Lincoln Pharmaceuticals' manufacturing capabilities, potentially increasing Aminophylline production and export capacity.
Impact: This merger is expected to enhance Lincoln Pharmaceuticals' manufacturing capabilities, potentially increasing Aminophylline production and export capacity.
Common Questions — Aminophylline Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which aminophylline supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, LINCOLN PHARMACEUTICALS LTD leads with 19 recorded shipments worth $3.1M. ARCO PHARMA PRIVATE LIMITED (19 shipments) and SRS PHARMACEUTICALS PRIVATE LIMITED (7 shipments) are also established high-volume exporters.
Q How many aminophylline manufacturers are there in India?
India has 151 active aminophylline exporters with a combined export market of $5.9M across 582 shipments to 88 countries. The top 5 suppliers hold 66.8% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for aminophylline from India?
Average FOB unit price: $2.50 per unit, ranging from $0.00 to $116.94. Average shipment value: $10.1K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 151 verified Indian exporters of Aminophylline ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 582 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 88 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
582 Verified Shipments
151 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists